On the other hand, dBET1 was shown to evoke a rapid degradation of BRD4, followed by the blockade of MYC transcription, and induction of apoptosis in AML cell lines and primary cultures, as well as in an AML xenograft model [108]. This evidence concerns the gene BRD4 and acute myeloid leukemia.